Wednesday Addenda

P4-452

Resting Bold fMRI Differentiates Dementia With Lewy Bodies vs. Alzheimer’s Disease
James Galvin, Joseph Price, Zhizi Yan, John Morris, Yvette Sheline

P4-453

Genome-Wide Association Analysis Using Cerebrospinal Fluid Abeta42 Levels as an Endophenotype for Alzheimer's Disease
John  Kauwe, Carlos Cruchaga, David McKean, Matthew Bailey, David Patty, Kevin Mayo, Sarah Bertelsen, Anthony Hinrichs, The Alzheimer's Disease Genetics Consortium, The Alzheimer's Disease Neuroimaging Initiative, Anne Fagan, David Holtzman, Alison Goate

P4-454

A Long-Term, Open-Label Extension Study Evaluating the Safety of Extended-Release Memantine (28 mg) in Patients With Moderate to Severe Alzheimer’s Disease
James Perhach, Stephen Graham

P4-455

Perivascular Drainage of Aβ is Disrupted in the Brains of Mice Expressing the Human Apolipoprotein E4 Allele
Cheryl Hawkes, Patrick Sullivan, Roy Weller, James Nicoll, Roxana Carare

P4-456

Divergent Modulation of Inflammation in Astrocytes Drives Alzheimer's Pathology
Ana Fernandez

P4-457

Accuracy of ß-Amyloid PET With Florbetaben in Alzheimer‘s Disease (AD) Patients and Healthy Volunteers (HVs) – Influence of Scan Duration
Osama Sabri, Solveig Tiepolt, Marianne Patt, Swen Hesse, Gertz Herman-Josef, Cornelia Reininger, Henryk Barthel

P4-458

Aging in Place With Dementia: The Design of a Digital Tool for Environmental Modifications
Helianthe Kort

P4-459

Evidence for the Involvement of the RSG2 Gene in Risk for Anxiety and Related Phenotypes in an Elderly Population not Selected for This Trait
Corinne Lendon, Herlina Handoko,  Antonia Pritchard, Penelope Lind, Peter Bentham, Grant Montgomery, Naomi Wray, Soo-Keat Khoo, Nancy Pachana, Gerard Byrne

P4-460

Attenuated Anti-Aggregation Effects of Magnetite Nanoparticles in Cerebrospinal Fluid of People With Alzheimer Disease
Daniela Ripova, Zuzana Gazova, Andrea Antosova, Zdena Kristofikova, Ales Bartos, Jan Ricny

P4-461

Comparison of Placebo Responses in Alzheimer’s Disease Clinical Trials
Kaori Ito, David Li, Brian Corrigan

P4-462

The Impacts of LXR Ligand TO901317 on Amyloid-β Levels and Cholesterol Metabolism in Niemann-Pick Type C (NPC) Model Cells
Jasminka Stefulj, Martina Malnar, Cornelia Schweinzer, Marko Kosicek, Jelena Zivkovic, Ute Panzenboeck, Silva Katusic Hecimovic

P4-463

The Crystal Structure of Death Receptor 6 (DR6): A Potential Receptor of the Amyloid Precursor Protein (APP)
Miriam Küster, Steffen Kemmerzehl, Sven Dahms, Dirk Roeser, Manuel Than

P4-464

Structural and Biochemical Analysis of the Heparin-Induced E1 Dimer of the Amyloid Precursor Protein
Sven Dahms, Sandra Hoefgen, Dirk Roeser, Manuel Than

P4-465

No Title
Sarah Pakzad

P4-466

The Relationship Between Informant and Performance-Based Measures of Everyday Function
Sarah Tomaszewski Farias, Dan Mungas, Bruce Reed

P4-467

An Index of Vascular Health is Associated With White Matter and Hippocampal Changes in Individuals With Mild Cognitive Impairment
Angela Jefferson, Katherine Gifford, George Chapman, Vitaly Dobrmyslin, Joseph Palmisano, Amanda Gentile, Yorghos Tripodis, David Salat

P4-468

Subjective Complaint and Cognitive Aging
Yorghos Tripodis, Joseph Palmisano, Amanda Gentile, Angela Jefferson

P4-469

Chronic Treatment With Rivastigmine Does Not Modify Primary Motor Cortex Synaptic Plasticity in Patients With Alzheimer’s Disease (AD): A Repetitive Transcranial Magnetic Stimulation (rTMS) Study
Alessandro Trebbastoni, Fabrizia D'Antonio, Alessandra Campanelli, Maria Gabriele, Massimiliano Prencipe, Maurizio INGHILLERI, Carlo De Lena

P4-470

Characterizing Biomarker Dynamics Along the Alzheimer’s Disease Trajectory
John Becker, Christopher Gidicsin, Jacqueline Maye, Reisa Sperling, Keith Johnson

P4-471

Ameliorative Effect of Centella Asiatica on Memory Dysfunction in D-Galactose Induced Senescence Mice
Atish Prakash, Anil Kumar

P4-472

Vasogenic Edema in the Setting of ß-Amyloid Lowering Therapy, Adverse Event: What is it and How is it Detected?
Jerome Barakos, Christopher Carlson, Wahiba Estergard, Joonmi Oh, Joyce Suhy, Clifford Jack, Eric Siemers

P4-473

Frontolimbic Brain Regions Associated With Agitation and Aggression Symptoms in MCI and AD over a 2-year Period
Paula Trzepacz, Peng Yu, Phanikumar Bhamidipati, Brian Willis, Tammy Forrester, Linda Tabas, Adam Schwarz, Andrew Saykin

P4-474

Correlation of White Matter Lesions With Lacunar Infarcts in Patients With Mixed Alzheimer’s Disease With Subcortical Vascular Lesion
Heeyoung Kim, Jae-Hong Lee, Rahyeong Juh, Youngjoo No, Miseon Kwon

P4-220

Efficacy of High-Dose, Extended-Release Memantine (28 mg, once daily): Post hoc Responder Analysis From a Randomized Trial in Patients With Moderate to Severe Alzheimer's Disease
Stephen Graham (original presenting author), Suzanne Hendrix, Michael Miller, Vojislav Pejovic, Michael Tocco